Evidence map›Paper›PMID 25062958›Full record

ArticleCardiovascular research2014

Bidirectional cross-regulation between the endothelial nitric oxide synthase and β-catenin signalling pathways.

Christina M Warboys, Nan Chen, Qiuping Zhang, Yasin Shaifta, Genevieve Vanderslott, Gabriella Passacquale, Yanhua Hu, Qingbo Xu, Jeremy P T Ward, Albert Ferro

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Christina M WarboysCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK.
Nan ChenCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK.
Qiuping ZhangCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK.
Yasin ShaiftaDivision of Asthma, Allergy, and Lung Biology, King's College London, London, UK.
Genevieve VanderslottCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK.
Gabriella PassacqualeCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK.
Yanhua HuCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK.
Qingbo XuCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK.
Jeremy P T WardDivision of Asthma, Allergy, and Lung Biology, King's College London, London, UK.
Albert FerroCardiovascular Division, Department of Clinical Pharmacology, British Heart Foundation Centre of Research Excellence, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London, UK albert.ferro@kcl.ac.uk.
British Heart Foundation · GBKing's College London · GB

Funding

British Heart Foundation PG/06/068/21100British Heart Foundation PG/12/16/29443Wellcome Trust WT087776MA
6 · The paper itself

Abstract

aimsβ-catenin has been shown to be regulated by inducible nitric oxide synthase (NOS) in endothelial cells. We investigated here whether β-catenin interacts with and regulates endothelial NOS (eNOS) and whether eNOS activation promotes β-catenin signalling. METHODS AND

resultsWe identified β-catenin as a novel eNOS binding protein in human umbilical vein endothelial cells (HUVECs) by mass spectroscopy and western blot analyses of β-catenin and eNOS immunoprecipitates. This was confirmed by in situ proximity ligation assay. eNOS activity, assessed by cGMP production and eNOS phosphorylation (Ser1177), was enhanced in β-catenin(-/-) mouse pulmonary endothelial cells (MPECs) relative to wild-type MPECs. eNOS activation (using adenosine, salbutamol, thrombin, or histamine), or application of an NO donor (spermine NONOate) or cGMP-analogue (8-bromo-cGMP) caused nuclear translocation of β-catenin in HUVEC as shown by western blotting of nuclear extracts. Exposure to spermine NONOate, 8-bromo-cGMP, or sildenafil (a phosphodiesterase type 5 inhibitor) also increased the expression of β-catenin-dependent transcripts, IL-8, and cyclin D1. Stimulation of wild-type MPECs with basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), spermine NONOate, 8-bromo-cGMP, or sildenafil increased tube length relative to controls in an angiogenesis assay. These responses were abrogated in β-catenin(-/-) MPECs, with the exception of that to bFGF which is NO-independent. In C57BL/6 mice, subcutaneous VEGF-supplemented Matrigel plugs containing β-catenin(-/-) MPECs exhibited reduced angiogenesis compared with plugs containing wild-type MPECs. Angiogenesis was not altered in bFGF-supplemented Matrigel.

conclusionThese data reveal bidirectional cross-talk and regulation between the NO-cGMP and β-catenin signalling pathways.

Indexed as

Neovascularization, PhysiologicAnimalsbeta CateninCells, CulturedCyclic GMPCyclic GMP-Dependent Protein KinasesEnzyme ActivationEnzyme ActivatorsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansHuman Umbilical Vein Endothelial CellsMice, Inbred C57BLNitric OxideNitric Oxide DonorsNitric Oxide Synthase Type IIIbeta CateninCTNNB1 protein, humanCTNNB1 protein, mouseCyclic GMPCyclic GMP-Dependent Protein KinasesEnzyme ActivatorsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaNitric OxideNitric Oxide DonorsNitric Oxide Synthase Type IIINOS3 protein, humanNos3 protein, mousePhosphodiesterase 5 InhibitorsSerineAngiogenesisBeta cateninGene transcriptionNitric oxide

Identifiers

PMID25062958
PMCPMC4375405
OpenAlexW2003719440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.